Cleveland HeartLab LLC
10265 Carnegie Avenue
Cleveland
Ohio
44106
United States
Tel: 216-444-9886
Website: http://www.clevelandheartlab.com/
Email: rrhea@clevelandheartlab.com
19 articles about Cleveland HeartLab LLC
-
Advantage Capital Portfolio Company Cleveland HeartLab, Inc. Acquired by Quest Diagnostics
10/20/2017
Advantage Capital portfolio company Cleveland HeartLab, Inc. announced its acquisition by Quest Diagnostics, one of the largest laboratory service providers in the country.
-
Quest Diagnostics to Acquire Cleveland HeartLab and Form Strategic Collaboration with Cleveland Clinic
10/19/2017
Quest Diagnostics today announced it has formed a definitive agreement to acquire Cleveland HeartLab, a leader in innovative diagnostic services for managing cardiovascular disease, from equity investors, including Cleveland Clinic.
-
Cleveland HeartLab LLC Adds Two Additional Patents To Its Extensive Intellectual Property Position For The Myeloperoxidase (MPO) Test, A Key Predictor Of Major Cardiac Events
5/4/2017
-
Cleveland HeartLab LLC Adds New Patent To Its Extensive Intellectual Property Position For The Myeloperoxidase (MPO) Test, A Powerful Biomarker For Inflammation And Its Role In Major Cardiac Events
2/22/2017
-
Cleveland HeartLab LLC Partners With SK Telecom To Provide Valuable Cardiovascular Testing In China
3/17/2016
-
Cleveland HeartLab LLC Launches Only Clinical Test For Measuring TMAO, An Important Measure Of Gut Dysfunction Associated With Cardiovascular Disease Risk
2/17/2016
-
Cleveland Clinic Partnering With Procter & Gamble And Cleveland HeartLab LLC To Advance Discovery In Heart Disease
8/20/2015
-
New Study Shows Cleveland HeartLab LLC Inflammation Testing Can Prevent Thousands Of Heart Attacks And Strokes, Averting $187 Million In Healthcare Costs For Cardiovascular Disease -- The Number One Killer Of Men And Women In The U.S.
4/21/2015
-
Cleveland HeartLab LLC Acquires MIRISK Heart Attack Risk Assessment Tool, Expanding Its Product Portfolio And Cardiovascular Disease Assessment Capabilities
1/7/2015
-
Cleveland HeartLab LLC Presents Research Demonstrating Its Prognostic Tests Can Save $180 Million In Healthcare Costs Related To Cardiovascular Disease, The Number One Killer Of Men And Women In The U.S.
6/2/2014
-
Cleveland HeartLab LLC Announces Speakers for its Fourth Annual Symposium on Cardiovascular Disease, Preventive Medicine
8/28/2013
-
Cleveland HeartLab LLC Expands Scientific, Sales Leadership Teams With Appointment of Three Key Executives
8/30/2012
-
Cleveland HeartLab LLC to Host Annual Symposium on Cardiovascular Disease, Wellness
8/7/2012
-
Cleveland HeartLab LLC’s Cardiovascular Disease Risk Testing to Be Featured at TEDMED 2012
4/5/2012
-
BG Medicine Announces Availability of Galectin-3 Testing Through Cleveland HeartLab LLC
10/27/2011
-
Cleveland HeartLab LLC to Sign Lease to Nearly Quadruple Office Space
9/20/2011
-
Cleveland HeartLab LLC Completes $18.4-Million Financing Round
8/22/2011
-
Cleveland HeartLab LLC to Host First Annual Symposium on Cardiovascular Disease
7/20/2010
-
Cleveland HeartLab LLC Raises $3 Million
3/3/2010